SCHEMBL7586822

SCHEMBL7586822

NC(CCCCCCO)(CCCCCCO)CCCCCCO

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 1/20 0.39
FFAR1 O14842 1/20 0.39
FFAR4 Q5NUL3 1/20 0.39
ARG2 P78540 2/20 0.39
LMNA P02545 3/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
ALDH1A1 P00352 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.38
CYP4F2 P78329 2/20 0.35
CYP4A11 Q02928 2/20 0.35
SMN1; SMN2 Q16637 1/20 0.33
CAMK2A Q9UQM7 1/20 0.30
ARG1 P05089 1/20 0.30
SMPD1 P17405 2/20 0.30
FDPS P14324 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7585089 1.00 GPR84 (0.39) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL21405561 1.00 GPR84 (0.39) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL1201076 0.97 ARG2 (0.40) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL5053890 0.97 ARG2 (0.40) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL414798 0.94 LMNA (0.41) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL14721620 0.88 LMNA (0.47) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL14481581 0.88 LMNA (0.37) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL1686256 0.88 LMNA (0.37) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL5056997 0.88 LMNA (0.37) GPR84FFAR1FFAR4ARG2LMNA
SCHEMBL6056307 0.87 LMNA (0.62) LMNAMEN1KMT2AALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1245249-A2 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug Aventis Pasteur (FR) 2002-10-02 EP disclosed
US-6124270-A IMMUNOLOGY, GENE THERAPY PASTEUR MERIEUX SERUMS ET VACCINS (FR) 2000-09-26 US disclosed
EP-0769942-A1 USE OF A CATIONIC AMPHIPATHIC COMPOUND AS A TRANSFECTION AGENT, VACCINE ADDITIVE OR DRUG PASTEUR MERIEUX SERUMS ET VACCINS (FR) 1997-05-02 EP disclosed
WO-1996032102-A1 USE OF A CATIONIC AMPHIPATHIC COMPOUND AS A TRANSFECTION AGENT, VACCINE ADDITIVE OR DRUG PASTEUR MERIEUX SERUMS ET VACCINS (FR) 1996-10-17 WO disclosed